Pharma-Bio Serv (PBSV) Net Cash Flow (2010 - 2026)

Pharma-Bio Serv's Net Cash Flow history runs 17 years deep, the most recent figure standing at -$4.0 million for Q2 2026.

• Net Cash Flow for Q2 2026 came in at -$4.0 million, up 24.59% year-over-year; the trailing twelve-month figure through Apr 2026 was -$321755.0 (up 77.64% YoY), and the FY2025 annual result was -$3.4 million, up 6.24% from the prior year.
• Net Cash Flow came in at -$4.0 million for Q2 2026 at Pharma-Bio Serv, down from $2.4 million in the prior quarter.
• In the past five years, Net Cash Flow ranged from a high of $7.6 million in Q4 2023 to a low of -$7.3 million in Q1 2023.
• A 5-year average of -$873916.7 and a median of -$170313.0 in 2022 frame the typical range for Net Cash Flow.
• The largest YoY upside for Net Cash Flow was 3008.91% in 2023 against a maximum downside of 577.36% in 2023.
• Over 5 years, Net Cash Flow stood at $245575.0 in 2022, then surged by 3008.91% to $7.6 million in 2023, then plunged by 96.73% to $249957.0 in 2024, then sank by 334.52% to -$586201.0 in 2025, then plunged by 577.37% to -$4.0 million in 2026.
• The last three Net Cash Flow figures came in at -$4.0 million (Q2 2026), $2.4 million (Q1 2026), and -$586201.0 (Q4 2025), per Business Quant data.